Literature DB >> 8113403

Prejunctional angiotensin II receptors. Facilitation of norepinephrine release in the human forearm.

B Clemson1, L Gaul, S S Gubin, D M Campsey, J McConville, J Nussberger, R Zelis.   

Abstract

To determine if peripheral angiotensin II (Ang II) prejunctional receptors facilitating NE release exist in humans, we used [3H]NE kinetic methodology to measure forearm NE spillover during intrabrachial arterial Ang II infusions in eight normal male subjects. We used the following protocol to optimize conditions for demonstrating these receptors: (a) lower body negative pressure (-15 mmHg) to increase sympathetic nerve activity to skeletal muscle; and (b) intraarterial nitroprusside to maintain a high constant forearm blood flow (approximately 10 ml/min.100 ml) to maximize the proportion of neuronally released NE that spills over into the circulation. During lower body negative pressure, the following were infused intraarterially for three consecutive 20-min periods: saline, Ang II (4 ng/min), and Ang II (16 ng/min). During the Ang II infusions, forearm venous NE increased significantly from 173 to 189 and 224 pg/ml (P < 0.01), and forearm NE spillover increased from 384 to 439 and 560 ng/min.100 ml (P < 0.05 for high Ang II). Forearm NE clearance was unchanged. During low and high dose Ang II, the plasma venous Ang II concentrations were 25 and 97 pM, respectively. Since normal subjects increase plasma Ang II from 4 to 20-22 pM with exercise, standing, or diuretic administration, and patients with severe congestive heart failure can have a plasma Ang II of approximately 25 pM at rest, we suggest that Ang II might facilitate NE release in severe congestive heart failure, especially under conditions of stress.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8113403      PMCID: PMC293901          DOI: 10.1172/JCI117021

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  42 in total

Review 1.  Regulation of noradrenaline release by presynaptic receptor systems.

Authors:  K Starke
Journal:  Rev Physiol Biochem Pharmacol       Date:  1977       Impact factor: 5.545

2.  Effects of lower body negative pressure on sympathetic discharge to leg muscles in humans.

Authors:  R G Victor; W N Leimbach
Journal:  J Appl Physiol (1985)       Date:  1987-12

3.  The effect of angiotensin II on endogenous noradrenaline release in man.

Authors:  P H Seidelin; W J Coutie; A D Struthers
Journal:  Br J Clin Pharmacol       Date:  1987-12       Impact factor: 4.335

Review 4.  Functions of angiotensin in the central nervous system.

Authors:  M I Phillips
Journal:  Annu Rev Physiol       Date:  1987       Impact factor: 19.318

5.  Abnormalities in systemic norepinephrine kinetics in human congestive heart failure.

Authors:  D Davis; R Baily; R Zelis
Journal:  Am J Physiol       Date:  1988-06

6.  Sympathetically mediated vasoconstriction is augmented by angiotensin II in man.

Authors:  D J Webb; P H Seidelin; N Benjamin; J G Collier; A D Struthers
Journal:  J Hypertens Suppl       Date:  1988-12

7.  Norepinephrine removal and release in the forearm of healthy subjects.

Authors:  P C Chang; J A van der Krogt; P Vermeij; P van Brummelen
Journal:  Hypertension       Date:  1986-09       Impact factor: 10.190

8.  Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity.

Authors:  G J Hasking; M D Esler; G L Jennings; D Burton; J A Johns; P I Korner
Journal:  Circulation       Date:  1986-04       Impact factor: 29.690

9.  A comparison of the effects of vasodilator stimuli on peripheral resistance vessels in normal subjects and in patients with congestive heart failure.

Authors:  R Zelis; D T Mason; E Braunwald
Journal:  J Clin Invest       Date:  1968-04       Impact factor: 14.808

10.  Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure.

Authors:  W N Leimbach; B G Wallin; R G Victor; P E Aylward; G Sundlöf; A L Mark
Journal:  Circulation       Date:  1986-05       Impact factor: 29.690

View more
  18 in total

1.  Exercise-induced inhibition of angiotensin II vasoconstriction in human thigh muscle.

Authors:  R Matthew Brothers; Mads L Haslund; D Walter Wray; Peter B Raven; Mikael Sander
Journal:  J Physiol       Date:  2006-09-14       Impact factor: 5.182

2.  Can intradermal administration of angiotensin II influence human heat loss responses during whole body heat stress?

Authors:  Naoto Fujii; Robert D Meade; Gabrielle Paull; Ryan McGinn; Imane Foudil-bey; Pegah Akbari; Glen P Kenny
Journal:  J Appl Physiol (1985)       Date:  2015-03-12

3.  Angiotensin AT1 receptor blockade abolishes the reflex sympatho-excitatory response to adenosine.

Authors:  G A Rongen; S C Brooks; S i Ando; B L Abramson; J S Floras
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

4.  Angiotensin II type 1 receptor blockade corrects cutaneous nitric oxide deficit in postural tachycardia syndrome.

Authors:  Julian M Stewart; Indu Taneja; June Glover; Marvin S Medow
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-11-09       Impact factor: 4.733

Review 5.  Angiotensin II, sympathetic nerve activity and chronic heart failure.

Authors:  Yutang Wang; Sai-Wang Seto; Jonathan Golledge
Journal:  Heart Fail Rev       Date:  2014-03       Impact factor: 4.214

6.  Myocardial perfusion in type 2 diabetes with left ventricular hypertrophy: normalisation by acute angiotensin-converting enzyme inhibition.

Authors:  Birger Hesse; Christian Meyer; Flemming S Nielsen; Asako Sato; Jens D Hove; Soeren Holm; Lia E Bang; Klaus F Kofoed; Tage L Svendsen; Hans-Henrik Parving; Lionel H Opie
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-12-05       Impact factor: 9.236

7.  Effects of the AT1-receptor antagonist eprosartan on the progression of left ventricular dysfunction in dogs with heart failure.

Authors:  George Suzuki; Takayuki Mishima; Elaine J Tanhehco; Victor G Sharov; Anastassia Todor; Sharad Rostogi; Ramesh C Gupta; Pervaiz A Chaudhry; Petros V Anagnostopoulos; Omar Nass; Sidney Goldstein; Hani N Sabbah
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

8.  Intradermal angiotensin II administration attenuates the local cutaneous vasodilator heating response.

Authors:  Julian M Stewart; Indu Taneja; Neeraj Raghunath; Debbie Clarke; Marvin S Medow
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-09       Impact factor: 4.733

9.  Regulation of peripheral vascular tone in patients with heart failure: contribution of angiotensin II.

Authors:  D E Newby; N E Goodfield; A D Flapan; N A Boon; K A Fox; D J Webb
Journal:  Heart       Date:  1998-08       Impact factor: 5.994

10.  The autonomic nervous system and ventricular arrhythmias in myocardial infarction and heart failure.

Authors:  Perry Wu; Marmar Vaseghi
Journal:  Pacing Clin Electrophysiol       Date:  2020-02-05       Impact factor: 1.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.